Analyses of liver enzymes after pretreatment with CCL2 receptor antagonists in AOM-treated mice demonstrated a significant reduction in the levels of ALT levels (Figure 3D) and bilirubin (Figure 3E) compared to AOM-treated mice alone, though levels were still.significantly elevated compared to controls indicating the presence of significant liver damage. The gene discussed is GPT; the disease is infectious otitis media.